LUNA INNOVATIONS INC
Industrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $109.5M | $87.5M | $11.6M | $14.8M | $8.8M | $6.6M |
| Operating income | −$1.9M | −$2.6M | −$845,000 | −$897,000 | −$373,000 | −$1.4M |
| Net income | $9.3M | $1.4M | −$1.1M | $1.1M | $149,000 | −$1.4M |
| Total assets | $151.0M | $130.2M | $131.0M | $86.5M | $75.6M | $66.2M |
| Total liabilities | $57.6M | $48.3M | $56.6M | $19.1M | $13.2M | $16.7M |
| Equity | $93.4M | $81.9M | $74.4M | $67.5M | $62.4M | $49.9M |
| EPS (diluted) | $0.28 | $0.04 | $-0.04 | $0.03 | $0.00 | $-0.05 |
| Shares out. | 32.3M | 31.4M | 30.4M | 28.1M | 28.4M | 27.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −1.7%
- Net margin
- 8.5%
- Return on equity
- 9.9%
- Return on assets
- 6.1%
- Return on capital (ROCE)
- −1.6%
- Liabilities / assets
- 38.1%
- Debt / equity
- 0.62×
- Book value / share
- $2.89
- Revenue growth (YoY)
- 25.1%
- Net income growth (YoY)
- 571.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- 3.93safe
- Accruals / assets
- 11.8%high accruals
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 12, 2024
- NT 10-Qmissed a reporting deadline ↗May 13, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 12, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2014
- NT 10-Qmissed a reporting deadline ↗Aug 17, 2009
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Royce & Associates LpPassive (13G)Jan 27, 2026
- Wasatch Advisors LpPassive (13G)May 12, 2025
- Prescott Group Capital Management, L.L.C.Passive (13G)Jan 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Changed auditorFeb 21, 2025
- Results of operations · Delisting / listing-standard noticeJan 27, 2025
- Delisting / listing-standard notice · Regulation FD disclosureJan 6, 2025
- Director / officer change · Regulation FD disclosureDec 27, 2024
- Delisting / listing-standard notice · Regulation FD disclosureNov 15, 2024
- Entered a material agreement · New financial obligation · Unregistered equity saleOct 29, 2024
- Director / officer change · Regulation FD disclosureOct 16, 2024
- Delisting / listing-standard notice · Regulation FD disclosureOct 7, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AJan 27, 2026
- SCHEDULE 13G/AMay 12, 2025
- 15-12GFeb 28, 2025
- 8-KFeb 21, 2025
- 25Feb 18, 2025
- 8-KJan 27, 2025
- SCHEDULE 13GJan 14, 2025
- 8-KJan 6, 2025
- 4FORM 4Jan 3, 2025
- 4FORM 4Jan 3, 2025
- 8-KDec 27, 2024
- 4FORM 4Dec 26, 2024
- NT 10-QNov 15, 2024
- 8-KNov 15, 2024
- SC 13GNov 14, 2024
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.